TapewireFind a company

person · Reporting owner

Williams Thomas Charles

Disclosed activity across 2 companies

Tapewire entity
77255
SEC CIK
0001474253

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
TWO RIVERS WATER & FARMING CoTURV · Entity 149637DirectorJanuary 30, 2019April 09, 2019
UPEXI, INC.UPXI · Entity 6954DirectorJuly 16, 2025July 24, 2025

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

TWO RIVERS WATER & FARMING Co

Report date January 30, 2019 · Filed April 09, 2019

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $0.13 · Expires 2029-01-30DirectNot disclosed Reported balance Holding disclosure · report date 2019-01-30 · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · Balance Not disclosed

UPEXI, INC.

Report date July 16, 2025 · Filed July 24, 2025

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect100,000 Ending reported balance After 2025-07-16 transaction · row 2
2 source rows · reconciled sequence

Row 1 · 2025-07-16 · Grant · Acquired 50,000 · Balance 50,000

F1: Vests in full 90 days from July 1, 2025.

F3: The shares of Common Stock reported herein were granted pursuant to the Issuer's Equity Incentive Plan.

Row 2 · 2025-07-16 · Grant · Acquired 50,000 · Balance 100,000

F2: Vests quarterly in equal installments over 12 months beginning July 1, 2025.

F3: The shares of Common Stock reported herein were granted pursuant to the Issuer's Equity Incentive Plan.

Filing footnotes · ownership attribution and instrument terms

F1: Vests in full 90 days from July 1, 2025.

F2: Vests quarterly in equal installments over 12 months beginning July 1, 2025.

F3: The shares of Common Stock reported herein were granted pursuant to the Issuer's Equity Incentive Plan.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
July 16, 2025 Filed Jul 24, 2025 16:03 UTC UPEXI, INC. UPXI · Entity 6954 GrantCommon Stock 50,000 $0.00 $0.00
Disclosure

SEC source: 0001477932-25-005237 · form4.xml · nonDerivative · entry 2

Williams Thomas Charles · CIK 0001474253 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

F2 · shares: Vests quarterly in equal installments over 12 months beginning July 1, 2025.

F3 · shares: The shares of Common Stock reported herein were granted pursuant to the Issuer's Equity Incentive Plan.

Read SEC document
July 16, 2025 Filed Jul 24, 2025 16:03 UTC UPEXI, INC. UPXI · Entity 6954 GrantCommon Stock 50,000 $0.00 $0.00
Disclosure

SEC source: 0001477932-25-005237 · form4.xml · nonDerivative · entry 1

Williams Thomas Charles · CIK 0001474253 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

F1 · shares: Vests in full 90 days from July 1, 2025.

F3 · shares: The shares of Common Stock reported herein were granted pursuant to the Issuer's Equity Incentive Plan.

Read SEC document
January 17, 2025 Filed Apr 25, 2025 16:01 UTC UPEXI, INC. UPXI · Entity 6954 GrantOptions to buy common stock · Derivative 25,000 $0.00 Strike: $3.46 $0.00
Disclosure

SEC source: 0001477932-25-002982 · form4.xml · derivative · entry 1

Williams Thomas Charles · CIK 0001474253 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2035-01-17

Read SEC document
September 30, 2022 Filed Nov 17, 2022 16:07 UTC UPEXI, INC. UPXI · Entity 6954 GrantStock Option Grant (right to buy) · Derivative 50,000 $0.00 Strike: $3.87 $0.00
Disclosure

SEC source: 0001415889-22-011491 · form4-11172022_091133.xml · derivative · entry 1

Williams Thomas Charles · CIK 0001474253 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2027-09-30

F1 · derivative.exercise_date: The option provides for vesting in equal monthly installments for the two-year period starting on July 1, 2022 and ending on July 1, 2024; therefore, on the grant date of September 30, 2022, such options immediately vested for 3 months and thereafter will continue to vest on a monthly basis for the succeeding 21 months.

F1 · derivative.expiration_date: The option provides for vesting in equal monthly installments for the two-year period starting on July 1, 2022 and ending on July 1, 2024; therefore, on the grant date of September 30, 2022, such options immediately vested for 3 months and thereafter will continue to vest on a monthly basis for the succeeding 21 months.

Read SEC document
July 21, 2021 Filed Aug 30, 2021 19:24 UTC UPEXI, INC. GRVI · Entity 6954 GrantOption Grant · Derivative 50,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001279925-21-000007 · primary_doc.xml · derivative · entry 1

Williams Thomas Charles · CIK 0001474253 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires not disclosed

F1 · derivative.exercise_price: 50,000 options are vested and shall be exercisable for a price of $4.18 per option share for 2 years from July 21, 2021 (the "Grant Date"); such options shall vest on a monthly basis over a one year period and be exercisable for a price of $4.18 per option share for two years from the Grant Date.

F1 · date: 50,000 options are vested and shall be exercisable for a price of $4.18 per option share for 2 years from July 21, 2021 (the "Grant Date"); such options shall vest on a monthly basis over a one year period and be exercisable for a price of $4.18 per option share for two years from the Grant Date.

F1 · price: 50,000 options are vested and shall be exercisable for a price of $4.18 per option share for 2 years from July 21, 2021 (the "Grant Date"); such options shall vest on a monthly basis over a one year period and be exercisable for a price of $4.18 per option share for two years from the Grant Date.

F1 · derivative.exercise_date: 50,000 options are vested and shall be exercisable for a price of $4.18 per option share for 2 years from July 21, 2021 (the "Grant Date"); such options shall vest on a monthly basis over a one year period and be exercisable for a price of $4.18 per option share for two years from the Grant Date.

F1 · derivative.expiration_date: 50,000 options are vested and shall be exercisable for a price of $4.18 per option share for 2 years from July 21, 2021 (the "Grant Date"); such options shall vest on a monthly basis over a one year period and be exercisable for a price of $4.18 per option share for two years from the Grant Date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.